Index
1 Medical Contrast Agent Market Overview
1.1 Product Overview and Scope of Medical Contrast Agent
1.2 Medical Contrast Agent Segment by Type
1.2.1 Global Medical Contrast Agent Market Value Comparison by Type (2024-2030)
1.2.2 Barium-based Contrast Media
1.2.3 Iodinated Contrast Media
1.2.4 Gadolinium-based Contrast Media
1.2.5 Microbubble Contrast Media
1.3 Medical Contrast Agent Segment by Application
1.3.1 Global Medical Contrast Agent Market Value by Application: (2024-2030)
1.3.2 Cardiovascular Disorders
1.3.3 Neurological Disorders
1.3.4 Gastrointestinal Disorders
1.3.5 Cancer
1.3.6 Nephrological Disorders
1.3.7 Musculoskeletal Disorders
1.3.8 Other Applications
1.4 Global Medical Contrast Agent Market Size Estimates and Forecasts
1.4.1 Global Medical Contrast Agent Revenue 2019-2030
1.4.2 Global Medical Contrast Agent Sales 2019-2030
1.4.3 Global Medical Contrast Agent Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Medical Contrast Agent Market Competition by Manufacturers
2.1 Global Medical Contrast Agent Sales Market Share by Manufacturers (2019-2024)
2.2 Global Medical Contrast Agent Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Medical Contrast Agent Average Price by Manufacturers (2019-2024)
2.4 Global Medical Contrast Agent Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medical Contrast Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Contrast Agent, Product Type & Application
2.7 Medical Contrast Agent Market Competitive Situation and Trends
2.7.1 Medical Contrast Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Contrast Agent Players Market Share by Revenue
2.7.3 Global Medical Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Contrast Agent Retrospective Market Scenario by Region
3.1 Global Medical Contrast Agent Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Medical Contrast Agent Global Medical Contrast Agent Sales by Region: 2019-2030
3.2.1 Global Medical Contrast Agent Sales by Region: 2019-2024
3.2.2 Global Medical Contrast Agent Sales by Region: 2025-2030
3.3 Global Medical Contrast Agent Global Medical Contrast Agent Revenue by Region: 2019-2030
3.3.1 Global Medical Contrast Agent Revenue by Region: 2019-2024
3.3.2 Global Medical Contrast Agent Revenue by Region: 2025-2030
3.4 North America Medical Contrast Agent Market Facts & Figures by Country
3.4.1 North America Medical Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Medical Contrast Agent Sales by Country (2019-2030)
3.4.3 North America Medical Contrast Agent Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medical Contrast Agent Market Facts & Figures by Country
3.5.1 Europe Medical Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Medical Contrast Agent Sales by Country (2019-2030)
3.5.3 Europe Medical Contrast Agent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Contrast Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Medical Contrast Agent Sales by Country (2019-2030)
3.6.3 Asia Pacific Medical Contrast Agent Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medical Contrast Agent Market Facts & Figures by Country
3.7.1 Latin America Medical Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Medical Contrast Agent Sales by Country (2019-2030)
3.7.3 Latin America Medical Contrast Agent Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Contrast Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Medical Contrast Agent Sales by Country (2019-2030)
3.8.3 Middle East and Africa Medical Contrast Agent Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Medical Contrast Agent Sales by Type (2019-2030)
4.1.1 Global Medical Contrast Agent Sales by Type (2019-2024)
4.1.2 Global Medical Contrast Agent Sales by Type (2025-2030)
4.1.3 Global Medical Contrast Agent Sales Market Share by Type (2019-2030)
4.2 Global Medical Contrast Agent Revenue by Type (2019-2030)
4.2.1 Global Medical Contrast Agent Revenue by Type (2019-2024)
4.2.2 Global Medical Contrast Agent Revenue by Type (2025-2030)
4.2.3 Global Medical Contrast Agent Revenue Market Share by Type (2019-2030)
4.3 Global Medical Contrast Agent Price by Type (2019-2030)
5 Segment by Application
5.1 Global Medical Contrast Agent Sales by Application (2019-2030)
5.1.1 Global Medical Contrast Agent Sales by Application (2019-2024)
5.1.2 Global Medical Contrast Agent Sales by Application (2025-2030)
5.1.3 Global Medical Contrast Agent Sales Market Share by Application (2019-2030)
5.2 Global Medical Contrast Agent Revenue by Application (2019-2030)
5.2.1 Global Medical Contrast Agent Revenue by Application (2019-2024)
5.2.2 Global Medical Contrast Agent Revenue by Application (2025-2030)
5.2.3 Global Medical Contrast Agent Revenue Market Share by Application (2019-2030)
5.3 Global Medical Contrast Agent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GE Healthcare Medical Contrast Agent Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Medical Contrast Agent Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bracco Imaging Medical Contrast Agent Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Guerbet Group
6.4.1 Guerbet Group Corporation Information
6.4.2 Guerbet Group Description and Business Overview
6.4.3 Guerbet Group Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guerbet Group Medical Contrast Agent Product Portfolio
6.4.5 Guerbet Group Recent Developments/Updates
6.5 Lantheus Medical Imaging
6.5.1 Lantheus Medical Imaging Corporation Information
6.5.2 Lantheus Medical Imaging Description and Business Overview
6.5.3 Lantheus Medical Imaging Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lantheus Medical Imaging Medical Contrast Agent Product Portfolio
6.5.5 Lantheus Medical Imaging Recent Developments/Updates
6.6 Nanopet Pharma
6.6.1 Nanopet Pharma Corporation Information
6.6.2 Nanopet Pharma Description and Business Overview
6.6.3 Nanopet Pharma Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nanopet Pharma Medical Contrast Agent Product Portfolio
6.6.5 Nanopet Pharma Recent Developments/Updates
6.7 CMC Contrast
6.6.1 CMC Contrast Corporation Information
6.6.2 CMC Contrast Description and Business Overview
6.6.3 CMC Contrast Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CMC Contrast Medical Contrast Agent Product Portfolio
6.7.5 CMC Contrast Recent Developments/Updates
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Corporation Information
6.8.2 Daiichi Sankyo Description and Business Overview
6.8.3 Daiichi Sankyo Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Daiichi Sankyo Medical Contrast Agent Product Portfolio
6.8.5 Daiichi Sankyo Recent Developments/Updates
6.9 Subhra Pharma Private
6.9.1 Subhra Pharma Private Corporation Information
6.9.2 Subhra Pharma Private Description and Business Overview
6.9.3 Subhra Pharma Private Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Subhra Pharma Private Medical Contrast Agent Product Portfolio
6.9.5 Subhra Pharma Private Recent Developments/Updates
6.10 Spago Nanomedical
6.10.1 Spago Nanomedical Corporation Information
6.10.2 Spago Nanomedical Description and Business Overview
6.10.3 Spago Nanomedical Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Spago Nanomedical Medical Contrast Agent Product Portfolio
6.10.5 Spago Nanomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Contrast Agent Industry Chain Analysis
7.2 Medical Contrast Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Contrast Agent Production Mode & Process
7.4 Medical Contrast Agent Sales and Marketing
7.4.1 Medical Contrast Agent Sales Channels
7.4.2 Medical Contrast Agent Distributors
7.5 Medical Contrast Agent Customers
8 Medical Contrast Agent Market Dynamics
8.1 Medical Contrast Agent Industry Trends
8.2 Medical Contrast Agent Market Drivers
8.3 Medical Contrast Agent Market Challenges
8.4 Medical Contrast Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer